학술논문
Safety and efficacy of Daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA Foundation cohorts
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
16000641